Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

Australasian Journal of Dermatology

Volumn 50, Issue 1, 2009, Pages 56-59

  De Zwaan, Sally E ^a   Iland, Harry J ^a   Damian, Diona L ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Corticosteroid adverse effects; Diabetes mellitus; Imatinib mesylate

Indexed keywords

AZATHIOPRINE; DAPSONE; FLUCLOXACILLIN; HYDROXYUREA; IMATINIB; IMMUNOGLOBULIN G; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POTASSIUM IODIDE; PREDNISONE; TOBRAMYCIN; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; MALE; OSTEOPENIA; PYODERMA GANGRENOSUM;

DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LEG ULCER; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

EID: 58249115001     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2008.00506.x     Document Type: Article

References (19)

1. Barham KL, Jorizzo JL, Grattan B, Cox NH. Vasculitis and neutrophilic vascular reactions. In : Burns T Breathnach S, Cox N, Griffiths C (eds). Rook's Textbook of Dermatology, Vol. 3, 7th edn. Oxford: Blackwell Science, 2004 49 : 36 9.
2. Richardson JB, Callen JP. Pyoderma gangrenosum treated successfully with potassium iodide. J. Am. Acad. Dermatol. 1993 28 : 1005 7.
3. Tutrone WD, Green K, Weinberg JM, Caglar S, Clarke D. Pyoderma gangrenosum: dermatologic application of hyperbaric oxygen therapy. J. Drugs Dermatol. 2007 6 : 1214 19.
4. Fujimoto E, Fujimoto N, Kuroda K, Tajima S. Leukocytapheresis treatment for pyoderma gangrenosum. Br. J. Dermatol. 2004 151 : 1090 2.
5. Cummins DL, Anhalt GJ, Monahan T, Meyerle JH. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br. J. Dermatol. 2007 157 : 1235 9.
6. Dirschka T, Kastner U, Behrens S, Altmeyer P. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J. Am. Acad. Dermatol. 1998 39 : 789 90.
7. Dobson CM, Parslew RA, Evans S. Superficial granulomatous pyoderma treated with intravenous immunoglobulin. J. Am. Acad. Dermatol. 2003 48 : 456 60.
8. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J. Am. Acad. Dermatol. 1995 32 : 140 2.
9. Hagman JH, Carrozzo AM, Campione E, Romanelli P, Chimenti S. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum. J. Dermatolog. Treat. 2001 12 : 19 22.
10. Meyer N, Ferraro V, Mignard MH, Adamski H, Chevrant-Breton J. Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: Two cases and review of the literature. Clin. Drug Investig. 2006 26 : 541 6.
11. Suchak R, Macedo C, Glover M, Lawlor F. Intravenous immunoglobulin is effective as a sole immunomodulatory agent in pyoderma gangrenosum unresponsive to systemic corticosteroids. Clin. Exp. Dermatol. 2007 32 : 205 7.
12. Zhang XB, He YQ, Zhou H, Luo Q, Li CX. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy. Chin. Med. J. (Engl.) 2006 119 : 1230 2.
13. Kreuter A, Reich-Schupke S, Stucker M, Altmeyer P, Gambichler T. Intravenous immunoglobulin for pyoderma gangrenosum. Br. J. Dermatol. 2008 158 : 856 7.
14. Swale VJ, Saha M, Kapur N, Hoffbrand AV, Rustin MH. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab. Clin. Exp. Dermatol. 2005 30 : 134 6.
15. Samitz MH, Greenberg MS. Skin lesions in association with ulcerative colitis. Gastroenterology 1951 19 : 476 9.
16. Ebringer A, Doyle AE, Harris GS. Dermonecrotic factor. I. Nature and properties of a dermonecrotic factor to guinea-pig skin found in human serum. Br. J. Exp. Pathol. 1969 50 : 559 65.
17. Lazarus GS, Goldsmith LA, Rocklin RE, Pinals RS, de Buisseret JP, David JR. Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch. Dermatol. 1972 105 : 46 51.
18. Tufan F, Kamali S, Erer B, Gul A, Inanc M, Ocal L, Konice M, Aral O. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases. Clin. Rheumatol. 2007 26 : 1913 15.
19. Nimmerjahn R, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 2008 26 : 513 33.